We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
News

Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS

Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
News

Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.

In February 2013, Quest Diagnostics announced it had entered into a definitive agreement to sell HemoCue to Radiometer, with plans to use the proceeds to repurchase approximately $300 million of Quest Diagnostics shares as part of the company's stock buyback program.

The transaction follows an announcement by Quest Diagnostics late last year that it would seek strategic alternatives for certain non-core business assets in order to concentrate on its diagnostic information services business. In December 2012, the company divested OralDNA Labs.

Advertisement